FDA FDA PMA approval: PearlMatrix Bone Graft — P240001, Jun 18, 2025. Applicant at approval: Cerapedics, Inc. source ↗
Trial start Not phased (device or behavioral study): Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation source ↗
Trial start Not phased (device or behavioral study): P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation source ↗
Trial start Not phased (device or behavioral study): An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation source ↗
Upcoming milestones
Feb 28, 2028 (ESTIMATED) · Not phased · P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation · NCT03438747
Estimated primary completion per ClinicalTrials.gov. Dates move.
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.